Synairgen Stock Soars 420% On Promise Of Inhaled COVID-19 Drug

Small Study Excites Investors

Covid19_Hospital_Room
Synairgen Drug Shows Potential For Hospitalized COVID-19 Patients • Source: Shutterstock

More from COVID-19

More from Scrip